Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OSBP | P22059 | 1/20 | 0.78 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.76 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.76 |
| ▸ | ST6GAL1 | P15907 | 2/20 | 0.75 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.74 |
| ▸ | GPBAR1 | Q8TDU6 | 5/20 | 0.72 |
| ▸ | CASP7 | P55210 | 3/20 | 0.72 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.72 |
| ▸ | TP53 | P04637 | 2/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.72 |
| ▸ | BLM | P54132 | 2/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.72 |
| ▸ | VDR | P11473 | 2/20 | 0.72 |
| ▸ | USP2 | O75604 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.72 |
| ▸ | MDM4 | O15151 | 1/20 | 0.72 |
| ▸ | MAPT | P10636 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Epicoprosterol SCHEMBL12607072 | 1.00 | OSBP (0.78) | OSBPOSBP2CYP2C19CYP2D6ST6GAL1 | |
| Epicoprosterol SCHEMBL16867279 | 1.00 | OSBP (0.78) | OSBPOSBP2CYP2C19CYP2D6ST6GAL1 | |
| Epicoprosterol SCHEMBL12453190 | 1.00 | OSBP (0.78) | OSBPOSBP2CYP2C19CYP2D6ST6GAL1 | |
| Epicoprosterol SCHEMBL12806627 | 1.00 | OSBP (0.78) | OSBPOSBP2CYP2C19CYP2D6ST6GAL1 | |
| Epicoprosterol SCHEMBL24632942 | 1.00 | OSBP (0.78) | OSBPOSBP2CYP2C19CYP2D6ST6GAL1 | |
| Epicoprosterol SCHEMBL11380074 | 1.00 | OSBP (0.78) | OSBPOSBP2CYP2C19CYP2D6ST6GAL1 | |
| Epicoprosterol SCHEMBL25267973 | 1.00 | OSBP (0.78) | OSBPOSBP2CYP2C19CYP2D6ST6GAL1 | |
| Epicoprosterol SCHEMBL11391325 | 1.00 | OSBP (0.78) | OSBPOSBP2CYP2C19CYP2D6ST6GAL1 | |
| Epicoprosterol SCHEMBL21000320 | 1.00 | OSBP (0.78) | OSBPOSBP2CYP2C19CYP2D6ST6GAL1 | |
| Epicoprosterol SCHEMBL22018677 | 1.00 | OSBP (0.78) | OSBPOSBP2CYP2C19CYP2D6ST6GAL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 317 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119633036-A | Separation and purification method of oxidation-resistant active chia seed polysaccharide | 新疆农业大学 | 2025-03-18 | — | — | CN | claimed |
| US-20240301138-A1 | POLMERIC TRANSFECTION REAGENTS TO DELIVER NUCLEIC ACIDS FOR HOST CELL MODIFICATION | RJH BIOSCIENCES INC. (CA) | 2024-09-12 | — | — | US | claimed |
| WO-2022150921-A1 | POLYMERIC TRANSFECTION REAGENTS TO DELIVER NUCLEIC ACIDS FOR HOST CELL MODIFICATION | RJH BIOSCIENCES INC. (CA) | 2022-07-21 | — | — | WO | claimed |
| US-11130890-B2 | Adhesive composition, adhesive sheet, and method for producing same | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2021-09-28 | — | — | US | claimed |
| US-8673271-B2 | Compositions for mouth containing an anionic surfactant having reduced astringency | KAO CORPORATION (JP) | 2014-03-18 | — | — | US | claimed |
| US-20120270177-A1 | DENTAL ULTRASONIC DRUG DELIVERY SYSTEM AND DENTAL ULTRASONIC DRUG DELIVERY METHOD | FUKUOKA UNIVERSITY (JP) | 2012-10-25 | — | — | US | claimed |
| EP-2514387-A1 | ULTRASONIC DRUG DELIVERY SYSTEM FOR DENTAL USE AND ULTRASONIC DRUG DELIVERY METHOD FOR DENTAL USE | Japan Health Sciences Foundation (JP) | 2012-10-24 | — | — | EP | claimed |
| US-7863470-B2 | Linear polyethylenimine-sterol conjugates for gene delivery | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2011-01-04 | — | — | US | claimed |
| US-20070154447-A1 | Linear polyethylenimine-sterol conjugates for gene delivery | FURGESON DARIN Y | 2007-07-05 | — | — | US | claimed |
| US-7183263-B2 | Linear polyethylenimine-sterol conjugates for gene delivery | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2007-02-27 | — | — | US | claimed |
| WO-2003097714-A1 | FAT BINDING USING INTER-POLYMER COMPLEX OF GLUCOSAMINE AND POLYACRYLIC ACID | RANBAXY LABORATORIES LIMITED (IN) | 2003-11-27 | — | — | WO | claimed |
| EP-1354604-A1 | Combinations for cardiovascular indications | G.D. Searle LLC. (US) | 2003-10-22 | — | — | EP | claimed |
| WO-2002087556-A9 | PROBUCOL MONOESTERS AND THEIR USE TO INCREASE PLASMA HDL CHOLESTEROL LEVELS AND IMPROVE HDL FUNCTIONALITY | ATHEROGENICS INC (US) | 2003-03-20 | — | — | WO | claimed |
| WO-2002087556-A2 | PROBUCOL MONOESTERS AND THEIR USE TO INCREASE PLASMA HDL CHOLESTEROL LEVELS AND IMPROVE HDL FUNCTIONALITY | ATHEROGENICS, INC. (US) | 2002-11-07 | — | — | WO | claimed |
| CN-1342091-A | Combinations of cardiovascular indications | SEARLE & CO (US) | 2002-03-27 | — | — | CN | claimed |
| EP-1140187-A1 | COMBINATIONS FOR CARDIOVASCULAR INDICATIONS | G.D. Searle LLC. (US) | 2001-10-10 | — | — | EP | claimed |
| WO-2000038725-A1 | COMBINATIONS FOR CARDIOVASCULAR INDICATIONS | G.D. SEARLE LLC (US) | 2000-07-06 | — | — | WO | claimed |
| EP-0251905-B1 | Esters of alginic acid | FIDIA SPA (IT) | 1994-11-02 | — | — | EP | claimed |
| CN-87104499-A | Novel alginic acid esters | — | 1988-04-06 | — | — | CN | claimed |
| US-3974188-A | PHOSPHATE | THE LION DENTIFRICE CO., LTD. (JA) | 1976-08-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070154447-A1 | Linear polyethylenimine-sterol conjugates for gene delivery | LDLR, CETP, CYP11A1 | OSBP 227/4885OSBP2 103/4885CYP2C19 4142/4885 |
| US-20240301138-A1 | POLMERIC TRANSFECTION REAGENTS TO DELIVER NUCLEIC ACIDS FOR HOST CELL MODIFICATION | POLRMT, POLM, PLTP | OSBP 1076/4885OSBP2 1216/4885CYP2C19 4822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.